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ABSTRACT
In the present work, controlled experimental infection
and transmission studies in domestic cattle (Bos
taurus) and water buffaloes (Bubalus bubalis) were
carried out to study the in vivo behaviour of bubaline
herpesvirus 1 (BuHV1). Two bovine and two buffalo
calves were infected with BuHV1 (20287N isolate) by
intranasal aerosolisation. Two sentinel cattle did not
receive the virus challenge, but were housed with
infected buffaloes to evaluate horizontal transmission.
All experimentally inoculated animals showed viral
infection and respiratory clinical signs. BuHV1
experimentally infected calves showed intermittent viral
excretion between 2 days and 18 days postinfection
(dpi) with a maximum titre of excretion of 106 TCID50/
ml and moderate rhinitis between 2 dpi and 20 dpi.
BuHV1 experimentally inoculated buffaloes showed
mild respiratory signs, which consisted mainly of
serous nasal secretions during the infection period.
Sentinel calves showed mucosal specific IgG1
antibodies at seven days postcontact. Viral DNA was
detected by PCR and sequencing in both buffaloes and
sentinel calves, which could be associated with latency.
In conclusion, this study showed the susceptibility of
cattle to BuHV1 after both experimental infection and
contact with infected buffaloes. These data increase the
scarce knowledge on the pathogenesis in natural host
and the susceptibility of cattle to BuHV1 experimental
infection.
INTRODUCTION
The Herpesviridae family includes nearly 200
viruses isolated from various host species
(E Thiry and others 2006). Host susceptibil-
ity to herpesviruses indicates that the viruses
have mainly co-evolved with their hosts,
leading to a close adaptation (Davison 2002).
However, ruminant α herpesviruses have
been reported to cross the species barrier
and adapt to other species (Julien Thiry and
others 2006). Bubaline herpesvirus 1
(BuHV1) belongs to the cluster of ruminant
α herpesviruses related to bovine herpesvirus
1 (BoHV1) (Julien Thiry and others 2006).
The latter has only been associated with sub-
clinical disease in water buffalo (Bubalus
bubalis) (St George and Philpott 1972,
Scicluna and others 2010). However,
Amoroso and others (2013) detected BuHV1
viral DNA on an aborted water buffalo fetus
by means of PCR. In a previous study, the
authors reported the molecular characterisa-
tion of ﬁve BuHV1 ﬁeld isolates obtained
from asymptomatic water buffaloes of north-
eastern Argentina for the ﬁrst time (Maidana
and others 2014). However, the susceptibility
of cattle to BuHV1 infections as well as the
ability of water buffaloes to transmit BuHV1
infections to cattle has not been studied yet.
In Argentina, water buffalo breeding repre-
sents an important economic alternative to
cattle breeding. This species, closely related
to cattle, is mainly reared in the north-
eastern part of the country, with a population
of around 100,000 animals in mixed buffalo-
cattle production systems (Maidana and
others 2014). Considering these data, the
aim of this study was to gain insights into
BuHV1 experimental infections of buffaloes
and cattle and into the epidemiological role
of cattle in BuHV1 natural infections.
MATERIALS AND METHODS
Viruses and cell culture
The BuHV1-20287N isolate used in this work
was obtained from a nasal swab of buffalo
(Maidana and others 2014). The virus was
propagated in MDBK cells and viral stocks
were produced after infection of MDBK cells
at a low multiplicity of infection, as previously
described (Romera and others 2014).
Experimental design of in vivo infections
and sample collection
Four male calves and two female buffaloes,
all aged six months, were randomly separated
in three groups of two animals each: (a)
buffalo test group (animals 174 and 992);
(b) cattle test group (animals 216 and 224);
and (c) sentinel cattle group (animals 223
and 229). Their naïve status for BuHV1,
BoHV1 and BoHV5 exposure was veriﬁed
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upon arrival and before experimental infection, by
ELISA and seroneutralisation test (SNT), as described
before (Romera and others 2014), as well as by virus iso-
lation attempts from nasal samples. Before inoculation,
all groups were strictly isolated from each other for two
days. Animal care and experimental procedures were
reviewed and approved by the Institutional Committee
for Care and Use of Experimental Animals
(CICUAE-CICVyA, National Institute of Agricultural
Technology (INTA, Argentina), protocol No. 41/2012).
Animals from both test groups were inoculated with 3 ml
BuHV1 (20287N isolate, fourth passage in MDBK cells),
containing a total dose of 107.5 TCID50/ml by intranasal
aerosolisation (1.5 ml in each nostril). The sentinel
cattle group received no virus challenge but was housed
with infected buffaloes beginning at 24 hours postinocu-
lation (pi) to evaluate horizontal transmission. Animals
were examined daily by a veterinarian who was not
aware of the treatment received by each animal. During
the next 21 days postinfection (dpi) or days postcontact
(dpc), viral excretion, clinical signs such as loss of appe-
tite, lesions of nasal, ocular and oral mucosa, and dis-
charge from the nose or eyes, as well as rectal
temperature and nervous signs, were checked. Rhinitis
was scored as follows: 0=absent, 1=slightly serous,
2=severely serous, 3=seromucous, 4=mucopurulent. At
21 dpi and 20 dpc, animals were sedated with aceproma-
zine (Acedan, Holliday Scott S.A., Argentina) by the
intramuscular route and then euthanased by barbiturate
overdose (Euthanyle, Brouwer, Argentina). Postmortem
examination was performed immediately after euthan-
asia and trigeminal ganglia and tonsil were collected.
Pieces of approximately 100 mg of trigeminal ganglia
and tonsil ganglia stored at −70°C were digested and
DNA was extracted using the QIAamp DNA Mini kit
(Qiagen, Tecnolab S.A., Argentina). DNA was subjected
to B Glicoprotein (gB) PCR, as described before (De
Carlo and others 2004), to examine the presence of
viral DNA. Amplicons of PCR were puriﬁed and
sequenced using BigDyeTerminator V.3.1 (Applied
Biosystems) and an ABI3500xl sequencer (Applied
Biosystems).
Blood samples were taken on the day of inoculation
and weekly after that until 20 dpi. Serum antibodies
against BuHV1 were measured by SNT as previously
described, with some modiﬁcations (Romera and others
2014). Brieﬂy, four replicates of six serial fourfold dilu-
tions of each sample (1:4 to 1:1024) were mixed in
96-well plates with an equal volume of the BuHV1 refer-
ence strain B6 containing 200 TCID50; this mixing led to
a ﬁnal neutralisation stage of 1:8 to 1:2048. Serum-virus
mixtures were incubated for one hour at 37°C and then
100 μl of the MDBK cell suspension at 200,000 cells/ml
±50,000 was added. After incubation for two to three
days at 37°C, plates were read microscopically for cyto-
pathogenic effects.
Every dpi or dpc, nasal and vaginal secretions were
collected via insertion of tampons in the ventral meatus
of the nasal cavity for 5 min and immediately dipped in
5 ml Eagle’s Minimal Essential Medium (E-MEM) con-
taining 5000 IU penicillin/ml, 2500 µg streptomycin/ml
and 10 µg amphotericin B/ml, as previously described
(Romera and others 2014). Tampons were centrifuged
and samples were stored at −80°C until used. Nasal
samples were taken daily from 0 dpi to 21 dpi.
Immediately after collection, nasal swabs were inoculated
onto MDBK cell monolayers: 0.1 ml of nasal ﬂuids was
inoculated onto 96-well μ-titre plates and 10-fold serial
dilutions were tested in 4 wells. Monolayers were
inspected until cytopathic effects appeared and virus
titres were calculated by the Reed and Muench method,
as previously described (Romera and others 2014). IgG1
antibodies in nasal secretions from cattle were deter-
mined by ELISA, as previously described (Romera and
others 2014).
RESULTS
Clinical observations and BuHV1 in vivo characterisation
All experimentally inoculated animals showed signs of
viral infection. Viral shedding, rectal temperature and
rhinitis scores are shown in Fig 1. One of the buffaloes
(174) shed virus continuously between days 2 and 5 pi and
showed intermittent viral excretion at day 7 pi, with a
maximum titre of excretion of 104.75 TCID50/ml at day 2
pi. The other buffalo (992) showed viral excretion at days
2 and 18 pi, with maximum titres of 102.2 TCID50/ml at
day 18 pi. One of the clinical signs shown by infected buf-
faloes was moderate rhinitis between days 2 and 20 pi. The
peaks of rectal temperature were 40.2°C and 39.9°C for
buffalo 174 at day 3 pi, and buffalo 992 at day 4 pi, respect-
ively. In addition, infectious virus was isolated from only
one calf of the sentinel group (cattle 223) at 18 dpc, with
101.75 TCID50/ml viral titre. Sentinel cattle showed moder-
ate rhinitis and body temperature variations between
37.6°C and 39.5°C during the study period. Both cattle
intranasally inoculated with BuHV1 (216 and 224) showed
intermittent viral excretion for 16 dpi with peak titres of
106 TCID50/ml and 10
5 TCID50/ml at 2 dpi and 6 dpi,
respectively. These animals showed serous nasal discharge
with varying degrees of severity, from mild to moderate
rhinitis and body temperatures over 39°C at 12 dpi.
Neither virus nor viral DNA was detected in vaginal secre-
tions of buffaloes in the present work. To test the presence
of latent BuHV1 DNA, PCR assays were performed using
samples from trigeminal ganglia and tonsil dissected after
euthanasia. Viral DNA was detected in the tonsil of buffalo
174 and in the trigeminal ganglia of sentinel calf 223
(Table 1). Sequence analysis of the ampliﬁcation products
obtained showed 100 per cent identity with the inoculated
virus. In addition, trigeminal ganglia and tonsil were
co-cultured with susceptible MDBK cells and monitored
for BuHV1 replication. No cytopathic effects were
observed in the cultures, indicating that the positive
PCR results were due to the presence of latent viral
genomes.
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FIG 1: Nasal virus shedding (a and b) rhinitis (c and d) and rectal temperature (e and f) in two buffaloes (992 and 174) and two
cattle (216 and 224) infected with bubaline herpesvirus 1 (BuHV1) (20287N strain). Virus shedding titres are expressed as log10
TCID50/ml nasal fluid. Rhinitis is scored as follows: 0, absence; 1, slightly serous; 2, severely serous; 3, seromucous; 4,
mucopurulent
TABLE 1: Humoral response after intranasal infection
Animal
Humoral response Latent phase
Nasal IgG1 titre (log) Seroconversion titre (log) Viral DNA in TG Viral DNA in Ton
Infected buffaloes 174 0 1.2 − +
992 0 0.9 − −
Sentinel cattle 223 0.6 0 + −
229 0.6 0 − −
Infected cattle 224 0.9 2.2 − −
216 0.9 2.2 − −
Detection of viral DNA in latent ganglia
TG, trigeminal ganglia; Ton, tonsil ganglia
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Humoral immune response
The humoral and mucosal responses speciﬁcally raised
by animals after the experimental infection are shown in
Table 1. Both buffaloes seroconverted at 21 dpi, with
titres of 1.2 (log10) and 0.9 (log10) for buffaloes 174
and 992, respectively.
Infected cattle seroconverted at 21 dpi, with maximum
IgG titres of 2.2 (log10). In both experimentally infected
cattle, IgG1 antibodies were detected at 7 dpi, with titres
of 0.9 (log10), and samples taken at 14 dpi and 20 dpi
were negative.
In sentinel cattle, humoral immune responses in
serum at 7 dpc, 14 dpc and 20 dpc were negative.
However, both animals showed mucosal IgG1 detected
only at 7 dpc, with titres of 0.6 (log10).
In summary, the data show that BuHV1 was able to
replicate in experimentally infected buffaloes and calves
and to be transmitted from infected buffalos to the
naive calves of the sentinel group.
DISCUSSION
This study describes the in vivo behaviour of a previously
identiﬁed BuHV1 isolate (20287N) from Argentina
(Maidana and others 2014). The results obtained demon-
strate the susceptibility of cattle to infection with BuHV1
by both experimental infection and transmission assays.
Cattle experimentally infected with BuHV1 excreted
virus from 2 dpi to 18 dpi. Moderate to severe rhinitis was
observed at 18 dpi. Seroconversion (2.2 antibody titre)
was detected at 21 dpi. The results of the present study
are similar to those of Scicluna and others (2010), who,
in a heterologous experimental infection assay, found
that buffaloes were infected with BoHV1. Cattle suscepti-
bility to BuHV1 was also shown by the transmission assay,
in which viral excretion was detected in one of the two
sentinel calves. Virus detection in only one animal and
with low titre could be due to the gregarious behaviour
towards individuals of the same species and/or to the low
viral titre excreted by buffaloes. However, despite the low
viral excretion of sentinel calves, viral transmission from
buffaloes to cattle was corroborated by the detection of
IgG1 mucosal antibodies in both animals. In addition,
viral BuHV1 DNA was detected in the trigeminal ganglia
of one calf, demonstrating infection by the virus and
onset of latency in the bovine species (Table 1). The pres-
ence of mucosal antibodies in 223 cattle conﬁrms contact
infection. Its infection was able to generate an immune
response, to make latency and reactivate at 18 dpc
although the authors could not detect viral excretion
during the ﬁrst seven days after contact.
Although the viral load and behaviour that favour the
efﬁcient transmission of BuHV1 from buffaloes to cattle
are still unknown, the results of the present study dem-
onstrate the susceptibility of cattle to infection with
BuHV1. This virus elicited mild to moderate disease
under experimental conditions, with rhinitis as the main
clinical sign. Neither depression nor weight loss was
observed during the study period. Despite the previously
reported high degree of genetic similarity between
BuHV1 and BoHV5 (Maidana and others 2014), no
nervous signs, which are characteristic of infections with
the latter, were observed in cattle infected with BuHV1.
The authors reproduced BuHV1 experimental infec-
tion of buffaloes by intranasal aerosolisation. Similar to
previous reports on BuHV1 pathogenesis (Montagnaro
and others 2014), the respiratory signs after infection
were mild, and consisted mainly of serous nasal secre-
tions during the infection period. As for rectal tempera-
ture, maximum values of 40.2°C were recorded at 3 dpi
and 4 dpi, coinciding with the peak of viral excretion.
These results are similar to those shown by Montagnaro
and others (2014), although they observed a higher
virus shedding period (10 days v 7 days). De Carlo and
others (2004) detected viral DNA in nasal and vaginal
secretions from day 5 to day 15 after immunosuppres-
sion. However, in the present work, neither virus nor
viral DNA was detected in vaginal secretions of buffaloes.
Seroconversion was detected in buffaloes by SNT with 1
(log10) titre, coinciding with the results of Montagnaro
and others (2014), who reported similar neutralising
antibody titres at 15 days postchallenge.
In addition, in the present work, viral DNA of a
BuHV1 was detected in infected buffalo tonsil, different
from the results reported by Scicluna and others (2010),
who only detected the presence of viral DNA in the tri-
geminal ganglion after BoHV1 infection of buffaloes.
Although the authors have not detected viral DNA in
latency organs (buffalo 992), it could be observed that
the virus made latency before 20 dpi because the
authors could detect viral DNA in the tonsil of buffalo
174. Hence the excretion in buffalo 992 at 18 dpi could
also be more due to the reactivation of the virus rather
than intermittency in viral excretion.
The present study and those of Montagnaro and
others (2014) indicate that experimental infections with
BuHV1 and BoHV1 in their natural hosts induce acute
infections with pathogenicity features similar to those of
other α herpesviruses. These data increase the knowl-
edge on the pathogenesis of BuHV1, which has been
scarcely studied, particularly regarding experimental
infections in cattle. It would be interesting to know
whether this event happens in mixed (cattle and buffa-
loes) farms. This information will allow the rational
design of sanitary measures that can decrease the risks
of viral co-circulation and interspecies barrier crossings,
with the consequent generation of genetic variants with
unknown virulence in mixed herds.
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